326 related articles for article (PubMed ID: 11186307)
1. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.
Wodarz D; Nowak MA
Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1059-70. PubMed ID: 11186307
[TBL] [Abstract][Full Text] [Related]
2. The persistence of CTL memory.
Wodarz D
Neth J Med; 2002 Aug; 60(7 Suppl):4-13; discussion 14-6. PubMed ID: 12430586
[TBL] [Abstract][Full Text] [Related]
3. A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment.
Wodarz D; Page KM; Arnaout RA; Thomsen AR; Lifson JD; Nowak MA
Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):329-43. PubMed ID: 10794051
[TBL] [Abstract][Full Text] [Related]
4. CD8 memory, immunodominance, and antigenic escape.
Wodarz D; Nowak MA
Eur J Immunol; 2000 Sep; 30(9):2704-12. PubMed ID: 11009106
[TBL] [Abstract][Full Text] [Related]
5. Helper-dependent vs. helper-independent CTL responses in HIV infection: implications for drug therapy and resistance.
Wodarz D
J Theor Biol; 2001 Dec; 213(3):447-59. PubMed ID: 11735291
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of HIV persistence: implications for vaccines and therapy.
Bremermann HJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):459-83. PubMed ID: 7627623
[TBL] [Abstract][Full Text] [Related]
7. The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination.
Altes HK; Wodarz D; Jansen VA
J Theor Biol; 2002 Feb; 214(4):633-46. PubMed ID: 11851372
[TBL] [Abstract][Full Text] [Related]
8. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
[TBL] [Abstract][Full Text] [Related]
10. Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children.
Buseyne F; Le Chenadec J; Corre B; Porrot F; Burgard M; Rouzioux C; Blanche S; Mayaux MJ; Rivière Y
J Infect Dis; 2002 Dec; 186(11):1589-96. PubMed ID: 12447734
[TBL] [Abstract][Full Text] [Related]
11. Defining CTL-induced pathology: implications for HIV.
Wodarz D; Krakauer DC
Virology; 2000 Aug; 274(1):94-104. PubMed ID: 10936092
[TBL] [Abstract][Full Text] [Related]
12. Multiple HIV-1 infection of cells and the evolutionary dynamics of cytotoxic T lymphocyte escape mutants.
Wodarz D; Levy DN
Evolution; 2009 Sep; 63(9):2326-39. PubMed ID: 19486149
[TBL] [Abstract][Full Text] [Related]
13. Elucidating the elite: mechanisms of control in HIV-1 infection.
O'Connell KA; Bailey JR; Blankson JN
Trends Pharmacol Sci; 2009 Dec; 30(12):631-7. PubMed ID: 19837464
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
[TBL] [Abstract][Full Text] [Related]
15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
16. Anti-HIV adaptive immunity: determinants for viral persistence.
Yamamoto H; Matano T
Rev Med Virol; 2008; 18(5):293-303. PubMed ID: 18416450
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIV-1-specific T-cells and increase of viral load during immunosuppressive treatment in an HIV-1 infected patient with Chlamydia trachomatis induced arthritis.
Harrer T; Bäuerle M; Bergmann S; Eismann K; Harrer EG
J Clin Virol; 2005 Nov; 34(3):224-30. PubMed ID: 16140574
[TBL] [Abstract][Full Text] [Related]
18. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
[TBL] [Abstract][Full Text] [Related]
19. Antigen burden is major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: potential implications for therapeutic immunization.
Tussey LG; Nair US; Bachinsky M; Edwards BH; Bakari J; Grimm K; Joyce J; Vessey R; Steigbigel R; Robertson MN; Shiver JW; Goepfert PA
J Infect Dis; 2003 Feb; 187(3):364-74. PubMed ID: 12552420
[TBL] [Abstract][Full Text] [Related]
20. New mechanisms of viral persistence in primary human immunodeficiency virus (HIV) infection.
Soudeyns H; Pantaleo G
J Biol Regul Homeost Agents; 1997; 11(1-2):37-9. PubMed ID: 9418159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
